226 related articles for article (PubMed ID: 32342810)
1. Moxifloxacin Hydrochloride-Loaded Eudragit® RL 100 and Kollidon® SR Based Nanoparticles: Formulation, In vitro Characterization and Cytotoxicity.
Kırımlıoğlu GY; Özer S; Büyükköroğlu G; Yazan Y
Comb Chem High Throughput Screen; 2021; 24(3):328-341. PubMed ID: 32342810
[TBL] [Abstract][Full Text] [Related]
2. Eudragit RL100 Based Moxifloxacin Hydrochloride and Ketorolac Tromethamine Combination Nanoparticulate System for Ocular Drug Delivery.
Salvi V; Pawar P
Pharm Nanotechnol; 2020; 8(2):133-147. PubMed ID: 32167436
[TBL] [Abstract][Full Text] [Related]
3. Formulation of sustained-release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit RLPO or Kollidon SR.
Sahoo J; Murthy PN; Biswal S; Manik
AAPS PharmSciTech; 2009; 10(1):27-33. PubMed ID: 19145487
[TBL] [Abstract][Full Text] [Related]
4. Moxifloxacin loaded nanoparticles of disulfide bridged thiolated chitosan-eudragit RS100 for controlled drug delivery.
Iqbal O; Shah S; Abbas G; Rasul A; Hanif M; Ashfaq M; Afzal Z
Int J Biol Macromol; 2021 Jul; 182():2087-2096. PubMed ID: 34087298
[TBL] [Abstract][Full Text] [Related]
5. Fast dissolving moxifloxacin hydrochloride antibiotic drug from electrospun Eudragit L-100 nonwoven nanofibrous Mats.
Giram PS; Shitole A; Nande SS; Sharma N; Garnaik B
Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():526-539. PubMed ID: 30184779
[TBL] [Abstract][Full Text] [Related]
6. An Ex Vivo Evaluation of Moxifloxacin Nanostructured Lipid Carrier Enriched In Situ Gel for Transcorneal Permeation on Goat Cornea.
Gade S; Patel KK; Gupta C; Anjum MM; Deepika D; Agrawal AK; Singh S
J Pharm Sci; 2019 Sep; 108(9):2905-2916. PubMed ID: 30978345
[TBL] [Abstract][Full Text] [Related]
7. Preparation, in vitro release and antibacterial activity evaluation of rifampicin and moxifloxacin-loaded poly(D,L-lactide-co-glycolide) microspheres.
Qiao Z; Yuan Z; Zhang W; Wei D; Hu N
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):790-798. PubMed ID: 30892092
[TBL] [Abstract][Full Text] [Related]
8. Oseltamivir phosphate loaded pegylated-Eudragit nanoparticles for lung cancer therapy: Characterization, prolonged release, cytotoxicity profile, apoptosis pathways and in vivo anti-angiogenic effect by using CAM assay.
Yurtdaş-Kırımlıoğlu G; Güleç K; Görgülü Ş; Kıyan HT
Microvasc Res; 2022 Jan; 139():104251. PubMed ID: 34520775
[TBL] [Abstract][Full Text] [Related]
9. Chemical synthesis of chitosan/silver nanocomposites films loaded with moxifloxacin: Their characterization and potential antibacterial activity.
Shah A; Yameen MA; Fatima N; Murtaza G
Int J Pharm; 2019 Apr; 561():19-34. PubMed ID: 30817984
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of Cyclosporine A loaded nanoparticles for ocular drug delivery: Cellular toxicity, uptake, and kinetic studies.
Aksungur P; Demirbilek M; Denkbaş EB; Vandervoort J; Ludwig A; Unlü N
J Control Release; 2011 May; 151(3):286-94. PubMed ID: 21241752
[TBL] [Abstract][Full Text] [Related]
11. Drug Release and Targeting: the Versatility of Polymethacrylate Nanoparticles for Peroral Administration Revealed by Using an Optimized In Vitro-Toolbox.
Beyer S; Moosmann A; Kahnt AS; Ulshöfer T; Parnham MJ; Ferreirós N; Wagner S; Wacker MG
Pharm Res; 2015 Dec; 32(12):3986-98. PubMed ID: 26216175
[TBL] [Abstract][Full Text] [Related]
12. Moxifloxacin loaded gelatin nanoparticles for ocular delivery: Formulation and in-vitro, in-vivo evaluation.
Mahor A; Prajapati SK; Verma A; Gupta R; Iyer AK; Kesharwani P
J Colloid Interface Sci; 2016 Dec; 483():132-138. PubMed ID: 27552421
[TBL] [Abstract][Full Text] [Related]
13. Investigation of moxifloxacin loaded chitosan-dextran nanoparticles for topical instillation into eye: In-vitro and ex-vivo evaluation.
Kaskoos RA
Int J Pharm Investig; 2014 Oct; 4(4):164-73. PubMed ID: 25426437
[TBL] [Abstract][Full Text] [Related]
14. Formulation and in vitro evaluation of polymeric enteric nanoparticles as dermal carriers with pH-dependent targeting potential.
Sahle FF; Balzus B; Gerecke C; Kleuser B; Bodmeier R
Eur J Pharm Sci; 2016 Sep; 92():98-109. PubMed ID: 27393341
[TBL] [Abstract][Full Text] [Related]
15. Development of gatifloxacin-loaded cationic polymeric nanoparticles for ocular drug delivery.
Duxfield L; Sultana R; Wang R; Englebretsen V; Deo S; Swift S; Rupenthal I; Al-Kassas R
Pharm Dev Technol; 2016 Mar; 21(2):172-9. PubMed ID: 26794936
[TBL] [Abstract][Full Text] [Related]
16. Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity.
Bin-Jumah M; Gilani SJ; Jahangir MA; Zafar A; Alshehri S; Yasir M; Kala C; Taleuzzaman M; Imam SS
Int J Nanomedicine; 2020; 15():7861-7875. PubMed ID: 33116505
[TBL] [Abstract][Full Text] [Related]
17. In-vitro release of acyclovir loaded Eudragit RLPO(®) nanoparticles for sustained drug delivery.
Gandhi A; Jana S; Sen KK
Int J Biol Macromol; 2014 Jun; 67():478-82. PubMed ID: 24755259
[TBL] [Abstract][Full Text] [Related]
18. Influence of magnesium stearate on the physicochemical and pharmacodynamic characteristics of insulin-loaded Eudragit entrapped mucoadhesive microspheres.
Momoh MA; Kenechukwu FC; Nnamani PO; Umetiti JC
Drug Deliv; 2015; 22(6):837-48. PubMed ID: 24670092
[TBL] [Abstract][Full Text] [Related]
19. A novel nanoparticles impregnated ocular insert for enhanced bioavailability to posterior segment of eye: In vitro, in vivo and stability studies.
Rathod LV; Kapadia R; Sawant KK
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():529-540. PubMed ID: 27987741
[TBL] [Abstract][Full Text] [Related]
20. Desloratadine-Eudragit
Yenilmez E
Turk J Pharm Sci; 2017 Aug; 14(2):148-156. PubMed ID: 32454606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
